NCT00174226View on ClinicalTrials.gov

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

January 31, 2006

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Atomoxetine

DRUG

Buspirone

Trial Locations (11)

10010

Pfizer Investigational Site, New York

27705

Pfizer Investigational Site, Durham

27710

Pfizer Investigational Site, Durham

32806

Pfizer Investigational Site, Orlando

60637

Pfizer Investigational Site, Chicago

84132

Pfizer Investigational Site, Salt Lake City

90095

Pfizer Investigational Site, Los Angeles

92103-8218

Pfizer Investigational Site, San Diego

92103-8620

Pfizer Investigational Site, San Diego

92103-8656

Pfizer Investigational Site, San Diego

05091

Pfizer Investigational Site, Woodstock

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY